OrbiMed’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $49.2M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $80.5K | Sell |
|
|||||
|
2022
Q2 | $122K | Sell |
|
|||||
|
2022
Q1 | $148M | Sell |
|
|||||
|
2021
Q4 | $145M | Sell |
|
|||||
|
2021
Q3 | $153M | Buy |
|
|||||
|
2021
Q2 | $132M | Sell |
|
|||||
|
2021
Q1 | $131M | Buy |
|
|||||
|
2020
Q4 | $92.4M | Buy |
|
|||||
|
2020
Q3 | $40.6M | Hold |
|
|||||
|
2020
Q2 | $45.6M | Buy |
|
|||||
|
2020
Q1 | $17.4M | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $145M | Buy |
|
|||||
|
2017
Q4 | $102M | Sell |
|
|||||
|
2017
Q3 | $175M | Sell |
|
|||||
|
2017
Q2 | $159M | Buy |
|
|||||
|
2017
Q1 | $136M | Sell |
|
|||||
|
2016
Q4 | $183M | Sell |
|
|||||
|
2016
Q3 | $267M | Sell |
|
|||||
|
2016
Q2 | $407M | Sell |
|
|||||
|
2016
Q1 | $422M | Sell |
|
|||||
|
2015
Q4 | $441M | Buy |
|
|||||
|
2015
Q3 | $378M | Buy |
|
|||||
|
2015
Q2 | $448M | Buy |
|
|||||
|
2015
Q1 | $282M | Sell |
|
|||||
|
2014
Q4 | $349M | Sell |
|
|||||
|
2014
Q3 | $316M | Buy |
|
|||||
|
2014
Q2 | $294M | Buy |
|
|||||
|
2014
Q1 | $246M | Buy |
|
|||||
|
2013
Q4 | $199M | Buy |
|
|||||
|
2013
Q3 | $77.9M | Sell |
|
|||||
|
2013
Q2 | $73.5M | Buy |
|